{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361699993904008448.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.14694/edbk_174176"}},{"identifier":{"@type":"URI","@value":"http://ascopubs.org/doi/pdfdirect/10.14694/EDBK_174176"}}],"dc:title":[{"@value":"Precision Oncology: Who, How, What, When, and When Not?"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381699993904008449","@type":"Researcher","foaf:name":[{"@value":"Lee Schwartzberg"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993904008448","@type":"Researcher","foaf:name":[{"@value":"Edward S. Kim"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993904008450","@type":"Researcher","foaf:name":[{"@value":"David Liu"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993904008451","@type":"Researcher","foaf:name":[{"@value":"Deborah Schrag"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"15488748"},{"@type":"EISSN","@value":"15488756"}],"prism:publicationName":[{"@value":"American Society of Clinical Oncology Educational Book"}],"dc:publisher":[{"@value":"American Society of Clinical Oncology (ASCO)"}],"prism:publicationDate":"2017","prism:volume":"37","prism:startingPage":"160","prism:endingPage":"169"},"reviewed":"false","url":[{"@id":"http://ascopubs.org/doi/pdfdirect/10.14694/EDBK_174176"}],"createdAt":"2017-05-31","modifiedAt":"2021-04-06","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/2050307417117550208","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Preparation of the standard cell lines for reference mutations in cancer gene-panels by genome editing in HEK 293 T/17 cells"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.14694/edbk_174176"},{"@type":"CROSSREF","@value":"10.1186/s41021-020-0147-2_references_DOI_HgUPNuTDtQlzMxy53FX1TIS5dDn"}]}